You are here

Scheduling delegate's final decisions, July 2016

Scheduling medicines and poisons

27 October 2016

Book pagination

Summary of delegate's final decisions

Part A - Final decisions on matters referred to an expert advisory committee

2. Scheduling proposals referred to the July 2016 meeting of the Advisory Committee on Chemicals Scheduling (ACCS#17)

Summary of delegate's final decisions
Substance Final decision
Direct Red 254

Schedule 6 - New Entry

DIRECT RED 254 except when included in Schedule 5.

Schedule 5 - New Entry

DIRECT RED 254 in preparations containing 30 per cent or less of Direct Red 254.

Index - New Entry

DIRECT RED 254

cross reference: 2-NAPHTHALENESULFONIC ACID, 7-AMINO-4-HYDROXY-3-[[P-[(P-SULFOPHENYL)AZO]PHENYL]AZO]-, BIS(TRIETHANOLAMINE) SALT

Schedule 5

Schedule 6

Implementation date: 1 February 2017

Aminopyralid

Schedule 6 - Current Entry

AMINOPYRALID except when included in Schedule 5.

Schedule 5 - Amend Entry

AMINOPYRALID in preparations containing 22 per cent or less of aminopyralid.

Implementation date: 1 February 2017

Metazachlor

Schedule 5 − New Entry

METAZACHLOR.

Implementation date: 1 February 2017

Quinoline

Schedule 6 - New Entry

QUINOLINE and its salts (excluding other derivatives).

Index - New Entry

QUINOLINE.

cross reference: 2,3-BENZAPYRIDINE

Schedule 6

Appendix E, Part 2

Appendix F, Part 3

Appendix E - QUINOLINE

Standard statements: A [for advice, contact a Poisons Information Centre (e.g. phone Australia 13 11 26; New Zealand 0800 764 766) or a doctor (at once)], E1 (if in eyes wash out immediately with water), S1 (if skin or hair contact occurs, remove contaminated clothing and flush skin and hair with running water).

Appendix F - QUINOLINE

Warning Statement: 79 (will irritate eyes).

Safety Directions: 1 (avoid contact with eyes), 4 (avoid contact with skin).

Implementation date: 1 February 2017

Phenoxymethyl oxirane

Schedule 6 - New Entry

PHENOXYMETHYL OXIRANE.

Appendix E - PHENOXYMETHYL OXIRANE

Standard Statements: A [for advice, contact a Poisons Information Centre (e.g. phone Australia 13 11 26; New Zealand 0800 764 766) or a doctor (at once)], E1 (if in eyes wash out immediately with water).

Appendix F - PHENOXYMETHYL OXIRANE

Warning Statements: 12 (vapour is harmful to health on prolonged exposure), 28 [(Over) (Repeated) exposure may cause sensitisation], 51 (irritant to skin, eyes, mucous membranes and upper respiratory tract).

Safety Directions: 1 (avoid contact with eyes), 3 (wear eye protection when mixing or using), 4 (avoid contact with skin), 5 (wear protective gloves when mixing or using), 7 (wash hands thoroughly after use), 8 (avoid breathing vapour), 9 (use only when in well-ventilated areas).

Implementation date: 1 February 2017

n-Hexane The current scheduling remains appropriate for n-hexane.
Amyl and hexyl cinnamaldehyde

Appendix B - New Entries

AMYL CINNAMALDEHYDE

HEXYL CINNAMALDEHYDE

Implementation date: 1 February 2017

Isoeugenol

Schedule 6 - Amend Entry

ISOEUGENOL except:

  1. when included in Schedule 5; or
  2. in preparations intended for contact with skin containing 0.5 per cent or less of isoeugenol.

Schedule 5 - Amend Entry

ISOEUGENOL in preparations not intended for skin contact containing 25 per cent or less of isoeugenol except in preparations intended for contact with skin containing 0.5 per cent or less of isoeugenol.

Implementation date: 1 June 2017

Book pagination